Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Design, optimization, and biological evaluation of a novel quinoline-based POLRMT inhibitor for prostate cancer therapy
Przykadowo, u kobiet jego poziom spada na pocztku menopauzy i utrzymuje si na niszym poziomie po menopauzie
In pre-clinical models, BPC 157 has been observed to: Upregulate vascular endothelial growth factor (VEGF) , promoting new blood vessel formation in damaged tissue Modulate nitric oxide (NO) synthesis pathways, influencing vascular tone and healing cascades Interact with the growth hormone receptor system , potentially amplifying downstream tissue repair signaling Demonstrate cytoprotective effects along the gastrointestinal tract its native home territory as a gastric peptide Exhibit apparent neuroprotective properties in rodent models of CNS injury BPC 157 stability in gastric acid unusual for peptides has made it a focus of GI mucosal repair research
Data Availability Data is available from the corresponding author upon request
Most long-term protocols settle at 12 mg per day because the doseresponse curve plateaus
Researchers can read our complete guide to bacteriostatic water for a deeper background on its composition, regulatory background, and laboratory use cases
US$ 21.35
US$ 28.51
US$ 22.52
